Optometry

This year was brimming with advancements in eye care.

The Glaucoma Symposium offers ophthalmology and optometry professionals an opportunity to sharpen their knowledge about glaucoma.

Refractive surgeons are likely to enjoy success with monovision for presbyopia if they aim for a maximum of 1.50 D of residual myopia in the non-dominant eye, exclude patients with pre-existing strabismus, and monitor for signs of strabismus.

Crosslinking meets the previously unmet needs of progressive keratoconus patients and provides an opportunity to increase engagement with optometrists, explain John Berdahl, MD, and George O. Waring IV, MD.

William Fredette, MD, discusse the results of two trials published in Opthalmology, which indicate that the combination of Verteporfin Photodynamic Therapy plus ranibizumab injections is no better than ranibizumab alone for treating subfoveal choroidal neovascularization secondary to AMD. Video provided by The Doctor's Channel.

As dry eye syndrome (DES) affects more and more patients over the next 10 years, pharmaceutical companies are expecting to expand their clinical products globally to treat the condition, thus tripling the market’s global revenue over the next decade.

Researchers have identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigments (RP).

The Welch Allyn facility in Beaverton, OR, earned Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.

Glaucoma may be a significant predictor of depression, according to research published in the American Journal of Ophthalmology.

A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after cataract surgery and provides patient satisfaction.

Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.

Gevokizumab, an IL-1 beta-modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis.

Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a $1 million donation made to the American Academy of Ophthalmology.

The Foundation Fighting Blindness is funding projects related to age-related macular degeneration, retinitis pigmentosa, Leber's congenital amaurosis, and Usher syndrome.

Fibrin glue might be a potential cause of toxic anterior segment syndrome (TASS).

Allergan and Molecular Partners AG have expanding their relationship with two new agreements for DARPin products.

The Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) and Pearson VUE partner to provide ophthalmic medical techs access to simulated exams.

Insight Software, creators of My Vision Express, has been ranked by Inc. magazine as one of the nation's fastest-growing private companies.

Prevent Blindness America (PBA) has designated September as Sports Eye Safety Awareness Month.

Check out this video demonstration of Swing Box, indoor golf net invented by Joe Lee, MD, ophthalmologist.

In a study from Emory University in Atlanta, ophthalmologists rated the same images higher on iPhone screens than desktop computer screens.

Lucentis, the 0.3-mg dose of ranibizumab injection, has been approved by the FDA for treatment of diabetic macular edema (DME).

A study, published in the Journal of Pediatric Ophthalmology and Strabismus, found exophoria to be a risk factor in 3D asthenopia (symptoms related to 3D viewing).

The formation of a new organization to represent all eye-care practitioners is one of the possibilities being considered by a task force examining ways that ophthalmologists and optometrists can collaborate to provide patient care.

Topcon Medical Systems has introduced a new computerized lensmeter (CL-300 Computerized Lensmeter) in U.S and Latin American markets.

A minimally invasive technique for the correction of refractive errors has good refractive predictability, is safe and effective, and has excellent stability up to 1 year postoperatively.

The recent issuance of revised recommendations for hydroxychloroquine retinopathy screening from the American Academy of Ophthalmology will have substantial effects on practicing ophthalmologists.

Data from 6 months of follow-up in a randomized, contralateral eye comparison study demonstrate LASIK performed using a proprietary "optimized prolate ablation" algorithm provides superior results compared with a conventional ablation technique.

Results from a small study indicate the feasibility, safety, and efficacy of improving near vision in patients with previous LASIK by implanting a small-aperture corneal inlay into a femtosecond laser-created corneal pocket.

The cornea maintains a better prolate shape after myopic PRK using a wavefront-optimized versus a wavefront-guided ablation profile.